Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Cogs-Excluding-Depreciation-and-Amortization" stands at 22.03 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2023.
Johnson & Johnson's third quarter result of 5.53 Billion USD for the item "Cogs Excluding Depreciation and Amortization" represents a decrease of -2.80 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 5.53 Billion USD for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 7.99 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 22.03 Billion USD for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 1.89 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.94 percent compared to the value the year prior.
The 1 year change in percent is 10.94.
The 3 year change in percent is -9.12.
The 5 year change in percent is 6.72.
The 10 year change in percent is 22.30.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cogs Excluding Depreciation and Amortization | 905,699,262,464.00 |
![]() | AbbVie Inc - Cogs Excluding Depreciation and Amortization | 399,570,305,024.00 |
![]() | Roche Holding AG - Cogs Excluding Depreciation and Amortization | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cogs Excluding Depreciation and Amortization | 280,205,508,085.11 |
![]() | Novartis AG - Cogs Excluding Depreciation and Amortization | 255,096,620,580.91 |